Stress Response Pathways in Vitiligo
NCT02797574 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2021-11-16
Summary
The purpose of this study is to investigate stress response pathways in tissues and melanocytes from patients with vitiligo. Investigators are collecting evidence of UPR and stress response activation in tissues and melanocytes from patients with vitiligo. Individuals with vitiligo will have punch biopsies to study stress response UPR activation and NF-κB signaling to test our hypothesis. In order to characterize differences between disease and normal states, a second arm of control individuals (Arm 2) will be recruited.
Conditions
- Vitiligo
Interventions
- PROCEDURE
-
Punch Biopsy at a Lesional Site
- PROCEDURE
-
Punch Biopsy at a Non- Lesional site
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Prashiela Manga, MD · New York University Medical School
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-10-31
- Primary Completion
- 2021-09-22
- Completion
- 2021-09-22
Countries
- United States
Study Locations
More Related Trials
-
A Study to Evaluate the Efficacy of Microneedling as a Stand-alone Treatment for Vitiligo
NCT05053022 ·Status: COMPLETED ·Phase: NA
-
Epidermal Cell Transplantation in Vitiligo Skin
NCT01629979 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Building an Assessment Model for Vitiligo Activity and Prognosis Using Peripheral Blood Cytokine Profiles
NCT07298551 ·Status: NOT_YET_RECRUITING
-
Response to Tregs in Innate Immunity Receptor LRP1 (CD91) and Tregs in Periferic Blood Mononuclear Cells in Patients With Non-segmentary Vitiligo
NCT03249064 ·Status: COMPLETED
-
ERASE VITILIGO Early Repigmentation Approach for Stopping the Evolution of VITILIGO Prospective Multicentric Interventional Study With Blinded Evaluation
NCT04843059 ·Status: COMPLETED ·Phase: NA
-
The Investigation on the Expression of High Mobility Group Protein Box-1 (HMGB1) in Peripheral Blood of Vitiligo Patients and Healthy Controls According to Clinical Features, Treatment and Disease Activity
NCT03741738 ·Status: COMPLETED
-
Sensory Symptoms in Active Vitiligo
NCT05390164 ·Status: UNKNOWN
-
Assessment of Circulating Fubctional Mitochondrias in Vitiligo Patients
NCT05525741 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Histochemical Study of Vitiligo in Sohag University Hospital Patients
NCT05869942 ·Status: UNKNOWN ·Phase: NA
-
A Study of the Safety and Tolerability of MEDI-551 in Scleroderma
NCT00946699 ·Status: COMPLETED ·Phase: PHASE1
-
Vitiligo Treatment by Targeting TYK2 Mediated Responses
NCT06327321 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Evaluation of Serum and Tissue Cathepsin L in Non-segmental Vitiligo Patients
NCT06261073 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Assessment of Hypoxia Inducible Factor and Autophagy Related Genes in Patients With Non-Segmental Vitiligo
NCT06410898 ·Status: RECRUITING ·Phase: NA
-
Autologous Non-cultured Epidermal Cell Suspension Transplantation in the Treatment of Vitiligo
NCT07187882 ·Status: RECRUITING ·Phase: NA
-
Induced Pluripotent Stem Cell Derived Exosomes Nasal Drops for the Treatment of Stable Vitiligo
NCT06810869 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Online Health Survey of Patients With Vitiligo Vulgaris/ Online Survey of Pediatric Patients With Vitiligo
NCT01401374 ·Status: COMPLETED
-
Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata
NCT03976622 ·Status: UNKNOWN
-
Establishing Fibroblast-Derived Cell Lines From Skin Biopsies of Patients With Immunodeficiency or Immunodysregulation Disorders
NCT00895271 ·Status: ENROLLING_BY_INVITATION
-
Questionnaire and Laboratory Data on Vitiligo Vulgaris
NCT01206374 ·Status: COMPLETED
-
Physiopathological Study and Pharmacological Modulation of Cutaneous Atrophy's Markers Induced by Glucocorticoids
NCT00709579 ·Status: UNKNOWN ·Phase: PHASE3
-
Western Sweden Systemic Sclerosis Project
NCT07345052 ·Status: RECRUITING
-
IL35 Level in Vitiligo
NCT05980390 ·Status: UNKNOWN
-
ASSESSMENT OF TRISTETRAPROLIN EXPRESSION IN LESIONAL SKIN OF PATIENTS WITH NON SEGMENTAL VITILIGO
NCT05990309 ·Status: UNKNOWN ·Phase: NA
-
Safety, Tolerability, and Pharmacokinetics of CAT-192 (Human Anti-TGF-Beta1 Monoclonal Antibody) in Patients With Early Stage Diffuse Systemic Sclerosis
NCT00043706 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Skin Biopsy Specimens as Biomarkers of Systemic Sclerosis and Response to Mycophenolate Mofetil
NCT00853788 ·Status: COMPLETED